Clearstead Advisors, LLC Anika Therapeutics, Inc. Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 32 shares of ANIK stock, worth $318. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32
Previous 44
27.27%
Holding current value
$318
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ANIK
# of Institutions
118Shares Held
10.7MCall Options Held
0Put Options Held
0-
Trigran Investments, Inc.1.62MShares$16.1 Million2.92% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$16 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA781KShares$7.76 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA633KShares$6.29 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX601KShares$5.98 Million0.0% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $145M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...